A Multi centric, Single Blind, Randomized, parallel group study to compare efficacy and safety of coded unani formulation UNIM-118 with Silymarin in patients with Waram al-Kabid/ Hepatitis A/B/C/E

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 632 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of both sexes.
•2. Patients in the age group of 18-65 years
•3. Patients with positive serological markers for at least for one of these â?? Hepatitis A/B/C/E
•4.Patients having total Bilirubin in the range of 2 -15 mg %
•5.• Patients with SGPT in the range of 105- 1000 IU/L
•6.• Any of the following symptoms and signs suggestive of viral hepatitis:
•ô??? Yaraqan Asfar (Yellow coloration of eye & skin)
•ô??? Iâ??ya (Fatigue)
•ô??? Wajaâ??al-Kabid (Hepatalgia)
•ô??? Zuâ??f al-Ishtihaâ?? (Anorexia)
•ô??? GhathayÄ?n (Nausea)
•ô??? Qai (Vomiting)
•ô??? Humma (Fever)
•ô??? Bawl Nasâ??e (Dark coloured urine)
•ô??? Siql-e-Tahtush Sharasif Aiman (Heaviness in the right hypochondrium)
•ô??? Lahib-e-Tahtush Sharasif Aiman (Burning sensation in the right Hypochondrium)
•ô??? Aversion to tea / smoking
•ô??? Naqs al-Wazn (Loss of weight)

•1.Patients with serum Bilirubin level 15 mg %
•2.Patients with complications of acute viral hepatitis
•3.Patients with signs of advanced liver disease, including muscle-wasting, ascites, peripheral oedema, dilated abdominal veins, and caput medusa
•4.H/o T.B./ D.M./ HIV/ CHF/ Malignancy/ Epilepsy
•5.USG suggestive of cirrhosis/ amoebic liver abscess/gall stones/ obstructive jaundice
•6.Alcoholics
•7.Pregnant and lactating women.
•8.Obese patients with BMI 30
•9.Patient on any other treatment including use of alternative medicine for hepatitis.

发起方

Central Council for Research in Unani Medicine CCRUM New Delhi